UnitedHealth Group (UNH) is reportedly moving toward a sale of its British healthcare technology arm, Optum UK. According to reports from Sky News, the U.S. private equity firm TPG (TPG) is the lead suitor in a deal estimated to be worth between £1.2 billion and £1.4 billion. While the negotiations are ongoing, the transaction would represent a massive shift in how the digital backbone of the National Health Service (NHS) is managed.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The deal highlights the growing value of medical data infrastructure. Here is the logic behind why TPG is targeting this specific corner of the UK healthcare market.
TPG Eyes a Potential Software Tie-Up
If the acquisition is successful, market experts believe TPG will pursue a roll-up strategy by merging Optum UK with Nextech, a U.S.-based medical software company it already owns. The logic of this combination is to create a global powerhouse in electronic patient record systems. By joining these two entities, TPG could streamline costs and share technology across different healthcare markets, making the business far more efficient.
UnitedHealth Moves to Recoup Recent Investments
The potential sale comes just two years after UnitedHealth acquired the business, which includes EMIS, a dominant supplier of software to the majority of British general practitioners. That original £1.24 billion deal only cleared UK regulators in 2023 after an investigation into market competition.
Industry analysts from BofA Securities, who are advising on the sale, note that UnitedHealth may be looking to simplify its international operations. By selling the unit now, the company could essentially break even on its initial investment while avoiding the long-term regulatory scrutiny that comes with owning such a large share of the UK’s primary care technology.
Private Equity Competition Drives Valuation
While TPG is currently the frontrunner, they aren’t the only ones interested in the “sticky” revenue of healthcare software. Other major firms, including Blackstone, have reportedly looked at the business. This competitive tension is what has pushed the potential price tag up toward the £1.4 billion mark.
The reason these firms are so interested is that electronic record systems are considered mission-critical infrastructure. Once a doctor’s office starts using a specific software to manage patient files, the cost and difficulty of switching to a new system are incredibly high. For private equity, this means predictable, long-term cash flows that are resistant to economic downturns.
Investors can compare both the stocks of UnitedHealth Group (UNH) and TPG (TPG) on the TipRanks Stocks Comparison Tool. Click on the image below to find out more.


